These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37530325)

  • 1. Evaluation of C-X-C chemokine receptor type 4 (CXCR4) and Peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in colorectal carcinoma: Relation to the available clinicopathological parameters.
    Bedeer AE; El-Ghaffar Heabah NA
    Indian J Pathol Microbiol; 2023; 66(3):465-471. PubMed ID: 37530325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of both peroxisome proliferator-activated receptor delta and cyclooxygenase-2 in tissues is associated with poor prognosis in colorectal cancer patients.
    Yoshinaga M; Taki K; Somada S; Sakiyama Y; Kubo N; Kaku T; Tsuruta S; Kusumoto T; Sakai H; Nakamura K; Takayanagi R; Muto Y
    Dig Dis Sci; 2011 Apr; 56(4):1194-200. PubMed ID: 20824502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of chemokine receptor CXCR4 in colorectal carcinoma and its relationship with clinicopathological parameters].
    Yu L; Shen Y; Li JK; Sun YH; Wang YC; Zhang JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):482-6. PubMed ID: 18803056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
    Richard CL; Blay J
    Int J Oncol; 2007 May; 30(5):1215-22. PubMed ID: 17390024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
    Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression.
    Duan FT; Qian F; Fang K; Lin KY; Wang WT; Chen YQ
    Mol Cancer; 2013 Dec; 12():164. PubMed ID: 24330809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
    Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
    Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
    Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
    González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
    J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
    Lu CL; Ji Y; Ge D; Guo J; Ding JY
    Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
    Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
    Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer.
    Yun SH; Roh MS; Jeong JS; Park JI
    Ann Diagn Pathol; 2018 Apr; 33():11-16. PubMed ID: 29566941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.